 WALTHAM, Mass., Sept. 07, 2022 GLOBE NEWSWIRE -- TScan Therapeutics, Inc. Nasdaq: TCRX, a clinical-stage biopharmaceutical company focused on the development of T cell receptor TCR engineered T cell therapies TCR-T for the treatment of patients with cancer, today announced that management will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference being held at the Sheraton New York in New York, NY on Wednesday, September 14, 2022 at 12:55 p.m. ET. 